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INTRODUCTION
Mediterranean spotted fever (MSF) is one of the
oldest recognised vector-borne infectious diseases.
The ﬁrst cases were described in Tunisia in 1909.
As characteristic skin eruptions were papular
rather than macular, the disease was referred to
as ‘boutonneuse’ fever. The eschar at the site of the
tick bite, the hallmark of rickettsial diseases, was
described in Marseille in 1925 by Boinet and Pieri
[1]. In the 1930s, the agent Rickettsia conorii and the
vector Rhipicephalus sanguineus, the brown dog tick
were described. Since that time, MSF is known by
clinicians to be endemic in Tunisia. Clinical
features are suggestive of diagnosis if the triad
(fever, rash and eschar) is present. However, cases
are rarely documented [2]. The second rickettsiosis
known in Tunisia is murine typhus, a frequently
underdiagnosed or misdiagnosed ﬂea-borne dis-
ease caused by R. typhi [1,3].
Immunoﬂuorescence assay (IFA) on serum
samples is used as a reference technique in most
laboratories for the diagnosis of human rickettsi-
oses. More recently, molecular methods based on
PCR ampliﬁcation and sequencing of rickettsial
target genes have helped to better characterise the
rickettsial bacteria involved. The objective of our
study was to conﬁrm the clinical diagnosis of
rickettsioses in humans in Tunisia by the use of
serological (IFA and Western blot analysis) and
molecular methods.
MATERIAL AND METHODS
Nine patients hospitalised for acute febrile illness between July
and August 2007, in the Infectious Diseases Unit of the
University Hospital of Sousse (3531¢52.07¢¢N, 1119¢42.49¢¢E),
and in the Paediatric Unit of the University Hospital of Mahdia
(3530¢15.84¢¢N, 1103¢57.96¢¢E) in the centre of Tunisia, were
investigated for rickettsial infection. Sera were collected and
cutaneous biopsies (two from eschar and two from maculo-
papular rash) were obtained from four patients.
Sera were tested by IFA and Western blot with cross-
adsorption studies for identiﬁcation of rickettsial strains at the
species level. DNA of blood was extracted by using the
QIAamp Tissue Kit (Qiagen GMBH, Hilden, Germany),
according to the manufacturer’s instructions, in the Laboratory
of Medical Entomology in the Institut Pasteur of Tunis. DNA
of cutaneous biopsies was extracted in Marseille, France.
Rickettsial DNA was detected by PCR using the primers
targeting the gltA gene and the primers targeting the OmpA
gene [4]. PCR products were puriﬁed and sequenced as
previously described [4]. All obtained sequences were assem-
bled and edited with Auto Assembler software (version 1.4;
Perkin-Elmer). Sequences were analysed by BLAST sequencing
analysis of the sequences in the GenBank database (see http://
www.ncbi.nlm.nih.gov/blast/).
RESULTS
Results of serological tests and cross-reactions of
nine sera tested revealed that three patients were
likely to be infected with spotted fever group
rickettsiosis (R. conorii) and six patients with
murine typhus (R. typhi) (Table 1). Sudden onset
of fever and headache was reported in all cases.
Among the four cutaneous biopsies, one was
PCR-positive (patient 8) and sequences of partial
gltA and OmpA were 100% identical to that of
R. conorii subsp. conorii [5].
DISCUSSION
By using reference methods including IFA and
Western blotting, our study conﬁrmed the
endemicity of MSF and murine typhus in Tunisia.
Furthermore, 99 years after the description of
MSF, we report here the ﬁrst molecular identiﬁ-
cation in Tunisia of the agent of the disease in an
inoculation eschar. Indeed, the nomenclature of
the several strains recognised as belonging to the
so-called R. conorii complex has been recently
modiﬁed and several species have been named,
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including R. conorii subsp. conorii subsp. nov.
(type strain = Malish, ATCC VR-613), the agent of
MSF [5].
On the other hand, murine typhus remains a
poorly known disease that is underestimated
because of non-speciﬁc symptoms leading to
misdiagnosing as MSF or viral infection. Less
than half of patients report exposure to ﬂeas or
ﬂea hosts. Diagnosis may be missed because the
rash is present in less than 50% of patients and is
often transient or difﬁcult to observe. Basically,
clinicians have to be aware of the presence of
murine typhus in Tunisia and should consider the
disease in patients presenting with unspeciﬁc
signs such as ‘fever of unknown origin’.
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Table 1. Result of serologic and molecular diagnosis
Case Clinical features Samples PCR
Indirect ﬂuorescent assay
Results of Western blot
after cross-adsorption
Rickettsia conorii Rickettsia typhi Rickettsia felis
IgG ⁄ IgM IgG ⁄ IgM IgG ⁄ IgM
1 Fever, rash Sera 0 ⁄ 0 0 ⁄ 0 0 ⁄ 0 Rickettsia typhi
2 Fever, rash Sera 0 ⁄ 128 32 ⁄ 256 0 ⁄ 128 Rickettsia typhi
3 Fever, rash Sera, skin biopsy (rash) Neg. 16 ⁄ 0 16 ⁄ 16 16 ⁄ 0 Rickettsia typhi
4 Fever, rash Sera 2048 ⁄ 1024 0 ⁄ 2048 512 ⁄ 512 Rickettsia conorii
5 Fever, rash Sera 64 ⁄ 0 0 ⁄ 256 0 ⁄ 0 Rickettsia typhi
6 Fever, rash Sera, skin biopsy (rash) Neg. 32 ⁄ 16 16 ⁄ 32 0 ⁄ 0 Rickettsia typhi
7 Fever, rash, Eschar Sera, skin biopsy (eschar) Neg. 256 ⁄ 16 0 ⁄ 0 0 ⁄ 0 Rickettsia conorii
8 Fever, rash, Eschar Sera, skin biopsy (eschar) Pos. (Rickettsia conorii) 2048 ⁄ 2048 16 ⁄ 2048 2048 ⁄ 2048 Rickettsia conorii
9 Fever, rash Sera 0 ⁄ 64 32 ⁄ 256 0 ⁄ 32 Rickettsia typhi
Neg: Negative, Pos: Positive.
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